Hee Kyung Ahn - Concepedia

Author

Hee Kyung Ahn

Gachon University Gil Medical Center ORCID

Also Known As

H K Ahn, H. Ahn, H.K. Ahn, Hee Kyung AHN, Hee Kyung Ahn, Hee-Jin Kim, Hee-Kyung Ahn, Hee-Seul Ahn, Heerak Ahn, Heong Ahn

287

Publications

Citations

H-Index

112

Concepts

All Affiliations

Gachon University Gil Medical Center Sungkyunkwan University Samsung Medical Center Gachon University Yonsei University

About

Hee Kyung Ahn is an author at Gachon University Gil Medical Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	33	1.5K
2	Health Sciences	12	12	504
3	Public Health	4	4	208
4	Engineering	1	1	127
5	Anatomy	1	1	20

Hee Kyung Ahn

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer Eun Young Kim, Young Saing Kim, Inkeun Park, Journal of Thoracic Oncology Ct-determined SarcopeniaMedicineMultiple Pulmonary NodulePathologyBronchial Neoplasm	2015	241
A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer Hee Kyung Ahn, Minkyu Jung, Sun Jin Sym, Cancer Chemotherapy and Pharmacology	2014	174
Physical Status and Expression of HPV Genes in Cervical Cancers Jong Sup Park, Eun Seong Hwang, Sue Nie Park, Gynecologic Oncology Hpv GenesCervical Cancer ScreeningCervical CancerCervical HealthHuman Papillomavirus Vaccines	1997	147
Volume-based assessment by 18F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer Seung Hyup Hyun, Hee Kyung Ahn, Hojoong Kim, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission Tomography18F-fdg Pet/ctNuclear MedicineEngineeringOncologic Imaging	2013	127
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial Yeon Hee Park, Tae‐Yong Kim, Gun Min Kim, The Lancet Oncology Breast OncologyMedicinePharmacologyGynecologyBreast Cancer	2019	120
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS K. Park, Johan Vansteenkiste, Ki Hyeong Lee, Annals of Oncology	2020	111
Implications of Bone-Only Metastases in Breast Cancer: Favorable Preference with Excellent Outcomes of Hormone Receptor Positive Breast Cancer Su Jin Lee, Silvia Park, Hee Kyung Ahn, Cancer Research and Treatment	2011	98
The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer Eun Young Kim, Young Saing Kim, Ja-Young Seo, PLoS ONE	2016	96
Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations Hee Kyung Ahn, Yeon Hee Park, Do Hyun Nam, Breast Cancer Research and Treatment Leptomeningeal MetastasesBreast OncologyMedicinePathologyBreast Cancer	2011	83
Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours Hee Kyung Ahn, Joon Young Choi, K.-M. Kim, British Journal of Cancer	2013	80

Page 1